Leeb-Lundberg L M, Cotecchia S, DeBlasi A, Caron M G, Lefkowitz R J
J Biol Chem. 1987 Mar 5;262(7):3098-105.
Continuous exposure of DDT1 MF-2 smooth muscle cells to 10-100 microM norepinephrine results in a dramatic attenuation of the ability of norepinephrine to stimulate inositol phospholipid hydrolysis via alpha 1-adrenergic receptors (alpha 1-AR). In addition to the functional desensitization, norepinephrine exposure also reduces the number of accessible cell surface alpha 1-AR as assayed by [3H]prazosin binding at 4 degrees C. Desensitization of the cells with norepinephrine results in an increase in the phosphorylation of the Mr 80,000 alpha 1-AR ligand binding peptide (2.4 +/- 0.2 mol of 32P per mol of alpha 1-AR; n = 5) when compared to control cells (1.1 +/- 0.1 mol of 32P per mol of alpha 1-AR; n = 5). The time courses of these three processes are all comparable being half-maximal within 1-2 min. These norepinephrine-promoted effects can be prevented by the alpha 1-AR receptor antagonist phentolamine indicating that they are mediated via the alpha 1-AR. Treatment of cells with the vasoactive peptide bradykinin (10 microM) induces desensitization of alpha 1-AR function similar to that induced by tumor-promoting phorbol ester treatment (Leeb-Lundberg, L. M. F., Cotecchia, S., Lomasney, J. W., DeBernardis, J. F., Lefkowitz, R. J., and Caron, M. G. (1985) Proc. Natl. Acad. Sci. USA 82, 5651-5655). Both treatments also result in phosphorylation of the alpha 1-AR, with stoichiometries of 1.7 +/- 0.1 (bradykinin; n = 5) and 3.6 +/- 0.1 (PMA; n = 5) mol of 32P/mol of alpha 1-AR. However, neither phorbol esters nor bradykinin reduce the number of accessible cell surface alpha 1-AR. Similar phosphopeptide maps are obtained from tryptic phosphopeptides generated from phosphorylated alpha 1-AR derived from cells treated with norepinephrine, phorbol 12-myristate 13-acetate, and bradykinin. Phosphoamino acid analysis reveals that the various agents induce phosphorylation on both serine and threonine residues. Thus, phosphorylation of receptors linked to the inositol phospholipid/Ca2+ signaling pathway may represent an important mechanism of regulation of receptor responsiveness.
将DDT1 MF - 2平滑肌细胞持续暴露于10 - 100微摩尔的去甲肾上腺素会导致去甲肾上腺素通过α1 - 肾上腺素能受体(α1 - AR)刺激肌醇磷脂水解的能力显著减弱。除了功能脱敏外,通过在4℃下用[3H]哌唑嗪结合测定,去甲肾上腺素暴露还会减少可及的细胞表面α1 - AR的数量。与对照细胞(每摩尔α1 - AR含1.1±0.1摩尔32P;n = 5)相比,用去甲肾上腺素使细胞脱敏会导致分子量为80,000的α1 - AR配体结合肽的磷酸化增加(每摩尔α1 - AR含2.4±0.2摩尔32P;n = 5)。这三个过程的时间进程都相当,在1 - 2分钟内达到最大值的一半。这些去甲肾上腺素促进的效应可被α1 - AR受体拮抗剂酚妥拉明阻止,表明它们是通过α1 - AR介导的。用血管活性肽缓激肽(10微摩尔)处理细胞会诱导α1 - AR功能脱敏,类似于肿瘤促进剂佛波酯处理所诱导的脱敏(利布 - 伦德伯格,L.M.F.,科泰基亚,S.,洛马斯尼,J.W.,德贝纳迪斯,J.F.,莱夫科维茨,R.J.,和卡隆,M.G.(1985年)《美国国家科学院院刊》82,5651 - 5655)。两种处理还都会导致α1 - AR的磷酸化,化学计量分别为每摩尔α1 - AR含1.7±0.1摩尔32P(缓激肽;n = 5)和3.6±0.1摩尔32P(佛波酯12 - 肉豆蔻酸13 - 乙酸酯;n = 5)。然而,佛波酯和缓激肽都不会减少可及的细胞表面α1 - AR的数量。从用去甲肾上腺素、佛波醇12 - 肉豆蔻酸13 - 乙酸酯和缓激肽处理的细胞衍生的磷酸化α1 - AR产生的胰蛋白酶磷酸肽中获得了相似的磷酸肽图谱。磷酸氨基酸分析表明,各种试剂都会诱导丝氨酸和苏氨酸残基的磷酸化。因此,与肌醇磷脂/Ca2 +信号通路相关的受体磷酸化可能代表了调节受体反应性的重要机制。